There is currently a lack of effective treatments for neurodegenerative diseases because of inadequate understanding and development of disease-associated therapeutic targets. An AI-based drug screening platform coupled with a novel strategy for building a biologics library will be constructed to identify neuroprotective factors and deliver new therapeutic solutions for Alzheimer’s disease, to accelerate the development of precision medicine that will benefit hundreds of millions of people globally.
3 Nov 2022
Research Program 3:
Identifying Systemic Targets and Treatment Strategies for Alzheimer’s Disease